XETRA - Delayed Quote EUR

Bio-Gate AG (BIG1.DE)

0.6850
+0.0450
+(7.03%)
At close: 5:36:02 PM GMT+2

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Marc Lloret-Grau Chairman of the Management Board, CEO & MD -- -- --
Thomas Konradt Director of Business Development & Member of Executive Board -- -- --

Bio-Gate AG

Neumeyerstrasse 28-34
Nuremberg, 90411
Germany
49 9 11 47 75 23 https://www.bio-gate.de
Sector: 
Healthcare
Full Time Employees: 
45

Description

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company's products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was incorporated in 2005 and is based in Nuremberg, Germany.

Corporate Governance

Bio-Gate AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 10:59 AM UTC - May 20, 2025 at 12:00 PM UTC

Bio-Gate AG Earnings Date

Recent Events

Related Tickers